Literature DB >> 26434760

Site Covalent Modification of Methionyl Peptides for the Production of FRET Complexes.

Pramodkumar D Jadhav1, Jianheng Shen2, Ramaswami Sammynaiken3, Martin J T Reaney4,5.   

Abstract

Flax cyclic peptides (orbitides, linusorbs (LOs)) [1-8-NαC],[1-MetO2]-linusorb B1 ([MetO2]-LO1) and [1-9-NαC],[1-MetO2]-linusorb B2 ([MetO2]-LO2) are biologically active. These LOs lack active nuclei commonly used in peptide modification. We have developed reactions to activate methionine methyl sulphide to produce stable derivatives. In these reactions, LOs are converted to sulfonium intermediates and subsequently to derivatives containing active nuclei while preserving their fundamental structures. The reaction conditions preserved cyclic peptide fundamental structure and organic solvent solubility. [Met]-LO1 and [Met]-LO2 analogues containing activated groups (-CN, -COOEt, and -NH2 ) in the form of methionine, methionine (S)-oxide, and methionine (S,S)-dioxide amino acids were synthesized and characterized by LCMS and 1D and 2D NMR spectroscopy. Coumarin orbitide complexes produced in this manner bind Eu(3+) yielding FRET compounds that absorb energy through coumarin antennae and emit photons at lanthanide wavelengths.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  FRET; alkylation; lanthanides; methionine; natural products; peptides

Mesh:

Substances:

Year:  2015        PMID: 26434760     DOI: 10.1002/chem.201502699

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Affinity binding of chicken apolipoprotein A1 to a novel flax orbitide (linusorb).

Authors:  Pramodkumar D Jadhav; Youn Young Shim; Martin J T Reaney
Journal:  RSC Adv       Date:  2018-05-15       Impact factor: 4.036

2.  Methionine epimerization in cyclic peptides.

Authors:  Pramodkumar D Jadhav; Jianheng Shen; Peta-Gaye Burnett; Jian Yang; Ramaswami Sammynaiken; Martin J T Reaney
Journal:  RSC Adv       Date:  2021-06-11       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.